Notably, SOCS1 and SOCS3 dysregulation intersect with host comorbidities such as obesity, type 2 diabetes, and metabolic syndrome, all of which are strongly associated with increased COVID‐19 severity and mortality [75, 76]. The gene discussed is SOCS3; the disease is COVID-19.